CSTONE PHARMA-B (02616) spent HKD 2.3513 million on repurchasing 500,000 shares on June 22.
Kisstone Pharma-B (02616) announced that on June 22, 2026, the company spent HK$2.3513 million to repurchase 500,000 shares at a repurchase price of HK$4.67-4.74 per share.
CSTONE PHARMA-B (02616) announced on June 22, 2026, that the company will spend 2.3513 million Hong Kong dollars to repurchase 500,000 shares, with a repurchase price of 4.67-4.74 Hong Kong dollars per share.
Related Articles
Robotic Intelligent Technology (300757.SZ): Issuance of H shares has obtained approval from the China Securities Regulatory Commission.
JXR(01951) suggests launching an asset-backed securities program on the Shanghai Stock Exchange.
STREAM IDEAS (08401): Huang Zilu appointed as executive director.
Robotic Intelligent Technology (300757.SZ): Issuance of H shares has obtained approval from the China Securities Regulatory Commission.
JXR(01951) suggests launching an asset-backed securities program on the Shanghai Stock Exchange.
STREAM IDEAS (08401): Huang Zilu appointed as executive director.
RECOMMEND
